Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC

NCT06864624 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Sunvozertinib

Sponsor

Tang-Du Hospital

Collaborators

[object Object]